After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: LUNA +14.6%, TEUM +11.1%, MARK +11%, FENG +6.1%, WOW +6%, (light volume), FSNN +3.3%, BGNE +3.2%, OREX +2.3%, DHT +0.8%
Companies trading higher in after hours in reaction to news: BWLD +28% (WSJ reporting that Roark Capital has made a bid to buy the co for more than $150/share), TCON +17.9% (announces that positive results from a Phase 1 clinical trial of TRC102 and Fludara in patients with advanced hematologic malignancies were published in the journal Oncotarget ), CLSN +6.6% (announced the submission of its Phase I/II clinical trial protocol to the U.S. Food and Drug Administration (FDA) for GEN-1, the Company's DNA-based immunotherapy for the localized treatment of ovarian cancer), GLBS +4.9% (announced that an investor holding warrants originally issued pursuant to the February 2017 private placement has elected to exercise its right to purchase 700,000 of the Company's common shares at a price of $1.60 per share), AMRN +4.3% (Amarin's Vascepa showed reductions in potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients with persistent high triglycerides and chronic kidney disease), ABUS +4.2% (ticking higher after confirming LNP licensee ALNY receives accelerated assessment of patisiran from European Medicines Agency)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: MRAM -11.6%, SWCH -6.6%, DAVE -5.1%, PBR -1.6%
Companies trading lower in after hours in reaction to news: MYO -13.4% (announced the filing of registration statement relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase common stock), PRQR -7.9% (to offer and sell ordinary shares in an underwritten public offering), ANTH -6.3% (filed for 28,613,474 share common stock offering by the selling stockholders ), TPRE -3.9% (commences underwritten secondary public offering of an aggregate of 15,000,000 of the common shares by holders), RPD -1.9% (indicated lower on block trade pricing), SAGE -1.8% (commences $300 mln common stock offering), QUOT -1.4% (commences $175 mln private placement of convertible senior notes due 2022), GDI -1.4% (commences 22 mln common stock offering by selling stockholders KKR), WTW -1% (intends to offer $500 mln in aggregate principal amount of senior notes due 2025 in a private offering)
MSCI announced the results of the November 2017 Semi‐Annual Index Review for the MSCI Equity Indexes
- MSCI Global Standard Indexes: Sixty-six securities will be added to and 56 securities will be deleted from the MSCI ACWI Index. In the MSCI World Index, the three largest additions measured by full company market capitalization will be Amundi (France), Allied Irish Banks (Ireland) and Drillisch (Germany). The three largest additions to the MSCI Emerging Markets Index measured by full company market capitalization will be China Molybdenum Co H (China), Polyus (Russia) and Grupo Carrefour Brasil (Brazil).
- MSCI Global Small Cap Indexes: There will be 351 additions to and 270 deletions from the MSCI ACWI Small Cap Index.
- MSCI Global Investable Market Indexes: There will be 332 additions to and 241 deletions from the MSCI ACWI Investable Market Index.
- MSCI Global Value and Growth Indexes: For the MSCI ACWI Value Index, the largest additions or style changes from Growth to Value will be Oracle Corp (USA ORCL), Altria Group (USA MO) and Honeywell International (USA HON). For the MSCI ACWI Growth Index, the largest additions or style changes from Value to Growth will be Royal Bank of Canada (Canada RY), Microsoft Corp (USA MSFT) and Abbvie (USA ABBV).
- MSCI US Equity Indexes: There will be seven securities added to and four securities deleted from the MSCI US Large Cap 300 Index. The three largest additions to the MSCI US Large Cap 300 Index measured by full company market capitalization will be Lam Research Corp (LRCX), Autodesk (ADSK), and Stanley Black & Decker (SWK).
- New positions in: NYRT (~11.23 mln shares), QCP (~1.08 mln), VNO (~0.84 mln), KRC (~0.82 mln), JBGS (~0.5 mln), CXP (~0.1 mln)
- Increased positions in: SRC (to ~14.99 mln shares from ~7.46 mln shares), FOR (to ~2.13 mln from ~0.66 mln), SLG (to ~2.74 mln from ~1.71 mln), H (to ~3.04 mln from ~2.66 mln), BXP (to ~0.4 mln from ~0.19 mln)
- Maintained positions in: PGRE (~14.61 mln shares), AIV (~5.93 mln)
- Closed positions in: FCE.A (from ~3.49 mln shares), RF (from ~2.39 mln), LOW (from ~0.93 mln), LSI (from ~0.3 mln)
- Decreased positions in: VER (to ~2.77 mln shares from ~19.22 mln shares), RPAI (to ~11.81 mln from ~13.28 mln), EQR (to ~1 mln from ~1.79 mln), CLGX (to ~0.23 mln from ~0.96 mln), TCO (to ~3.03 mln from ~3.46 mln), LQ (to ~1.16 mln from ~1.52 mln), MAC (to ~1.78 mln from ~2.1 mln), MSG (to ~0.32 mln from ~0.47 mln)